Latest Posters

Poster
Accelerate Drug Discovery With Small Molecule Microarrays
This poster explores how small molecule microarrays (SMM) simplifies the drug discovery workflow, from microarray printing to target screening, delivering fast, reliable results.

Poster
Rapid Generation of Bispecific Antibodies for High-Throughput Screening
This poster explores an innovative technology that simplifies the construction of bispecific antibodies, enabling rapid and efficient assembly of bispecific constructs while maintaining high purity and yield.

Poster
Meet Manufacturing Demand With Gentle, Size-Based Exosome Purification
This poster outlines a scalable workflow combining tangential flow filtration and size exclusion chromatography to effectively isolate and purify exosomes, removing contaminants including media, serum and host cell proteins, DNA and serum components.

Poster
Improving Physiological Relevance in Functional Genomics Screens
This poster describes the use of CRISPR-ready iPSCs, which are engineered to constitutively express Cas9, enabling the rapid generation of high-efficiency gene knockouts and CRISPR screens in a functional, physiologically relevant cell background.

Poster
Common Background Contamination Ions in Mass Spectrometry
With this poster, dive into the world of mass spectrometry troubleshooting, and discover detailed tables listing the accurate mass of elements, organic solvents and potential contaminant ions.

Poster
Accelerating Antibody Discovery Using BLI Biosensor Technology
Biolayer Interferometry (BLI) technology has greatly advanced the process of antibody discovery, and the latest platforms offer reliable, high precision analysis which researchers can rely on.

Poster
Accelerating Antibody Drug Development With Subdomain-Specific Affinity Chromatography
Affinity purification platforms such as Protein A or L are well-established in the manufacturing process of therapeutic monoclonal antibodies. However, with the development of engineered modalities such as bi-specific antibodies, fragments and Fc-fusion proteins, challenges in the downstream process of these molecules arise.

Poster
Kinetic Analysis: Spotting the Weakest Binders
Designing and performing assays that accurately measure small molecule binding kinetics is an important part of the drug discovery process. It allows researchers to predict the efficacy of potential novel therapeutics and make quick decisions about weak binders.

Poster
Discover a New Approach to Modeling Neurodegeneration
This poster demonstrates how a novel, precise and highly controlled iPSC reprogramming technology overcomes these limitations and enables the generation of mature cell types and isogenic models of neurodegenerative disease.

Poster
Optimized Human iPSC-Derived Sensory Neurons for Pain and Neuropathy Research
Many promising drugs which show efficacy in animal models have failed in the clinic due to interspecies variance in nociception mechanisms. Hence, consistent, scalable human in vitro models are required to accelerate potential therapeutics to the clinic.
Advertisement